Mitochondrial disease with epilepsy

Mitochondrial disease with epilepsy (Orphanet code 225700) is a broad clinical category encompassing a group of rare genetic disorders in which dysfunction of the mitochondria — the energy-producing structures within cells — leads to seizures (epilepsy) as a prominent feature. Because the brain has very high energy demands, it is particularly vulnerable to mitochondrial dysfunction. Epilepsy in the context of mitochondrial disease can manifest as focal seizures, generalized tonic-clonic seizures, myoclonic seizures, or epilepsia partialis continua, and may be progressive and drug-resistant. Mitochondrial diseases with epilepsy can affect multiple organ systems beyond the central nervous system, including skeletal muscle (myopathy, exercise intolerance), the heart (cardiomyopathy), the liver, the endocrine system (diabetes mellitus), the eyes (optic atrophy, pigmentary retinopathy), and the ears (sensorineural hearing loss). Well-known specific syndromes within this group include MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes), MERRF (myoclonic epilepsy with ragged red fibers), and Alpers syndrome, among others. Patients frequently exhibit developmental delay or regression, lactic acidosis, and progressive neurological deterioration. Treatment is largely supportive and symptomatic. Antiseizure medications are used to manage epilepsy, though certain drugs such as valproic acid may be contraindicated in some mitochondrial disorders (particularly those involving POLG mutations) due to the risk of hepatotoxicity. Nutritional supplements such as coenzyme Q10, L-carnitine, and B vitamins are sometimes used, although robust evidence for their efficacy is limited. Multidisciplinary care involving neurology, metabolic medicine, cardiology, and other specialties is essential. No curative therapy currently exists for most mitochondrial diseases with epilepsy, though gene therapy and other novel approaches are under investigation.

Common questions about Mitochondrial disease with epilepsy